Calidi Biotherapeutics Inc (CLDI)
0.2304
-0.01
(-4.79%)
USD |
NYAM |
May 17, 16:00
0.2304
0.00 (0.00%)
After-Hours: 20:00
Calidi Biotherapeutics Accounts Payable (Quarterly): 2.877M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.877M |
| September 30, 2023 | 1.491M |
| June 30, 2023 | 0.677M |
| Date | Value |
|---|---|
| December 31, 2022 | 2.271M |
| September 30, 2022 | 2.261M |
| December 31, 2021 | 0.624M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.624M
Minimum
Dec 2021
2.877M
Maximum
Dec 2023
1.700M
Average
1.876M
Median
Accounts Payable (Quarterly) Benchmarks
| Minerva Neurosciences Inc | 1.436M |
| Viking Therapeutics Inc | 5.225M |
| CytomX Therapeutics Inc | 1.964M |
| Genprex Inc | 1.398M |
| Janux Therapeutics Inc | 2.254M |